<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）在週五發佈的報告中，Wells Fargo &amp; Company 將其目標價格從 600.00 美元上調至 654.00 美元，MarketScreener 報道。該券商目前對這家醫療設備提供商的股票給予 “增持” 評級。Wells Fargo &amp; Company 的目標價格表明，相較於公司之前的收盤價，存在 19.48% 的潛在上漲空間。</p>
<p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
<ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
<p>其他一些券商最近也發佈了關於 ISRG 的報告。Leerink Partners 將直覺外科的目標價格從 593.00 美元上調至 600.00 美元，並在 10 月 22 日的研究報告中給予該公司 “跑贏大盤” 評級。Sanford C. Bernstein 在 10 月 21 日的研究報告中重申了 “跑贏大盤” 評級，並設定了 685.00 美元的目標價格。BTIG Research 在 10 月 22 日的報告中將直覺外科的目標價格從 529.00 美元上調至 589.00 美元，並給予該股票 “買入” 評級。Weiss Ratings 在 10 月 31 日的研究報告中重申了對直覺外科股票的 “持有（c）” 評級。最後，HSBC Global Research 在 10 月 23 日的研究報告中將直覺外科的股票評級上調至 “強力買入”。兩位股票研究分析師給予該股票 “強力買入” 評級，十六位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，共識目標價格為 608.79 美元。</p>
<p><strong>查看我們關於直覺外科的最新研究報告</strong></p>
<h2>直覺外科股票表現</h2>
<ul>
<li>在特朗普關税政策下表現突出的三隻股票</li>
</ul>
<p>NASDAQ:ISRG 週五開盤價為 547.36 美元。直覺外科的 52 周低點為 425.00 美元，52 周高點為 616.00 美元。該公司的 50 日移動平均價格為 527.82 美元，200 日移動平均價格為 505.98 美元。該公司的市值為 1962.2 億美元，市盈率為 72.40，市盈增長比率為 5.11，貝塔值為 1.68。</p>
<p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近於 10 月 21 日發佈了其財報。這家醫療設備提供商報告本季度每股收益（EPS）為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。該公司本季度的收入為 25.1 億美元，而分析師預期為 24.1 億美元。直覺外科的股本回報率為 15.08%，淨利潤率為 28.58%。直覺外科的季度收入同比增長 22.9%。在去年同期，該公司每股收益為 1.84 美元。整體來看，賣方分析師預測直覺外科在當前年度的每股收益將達到 6.43 美元。</p>
<h2>內部活動</h2>
<ul>
<li>為什麼直覺外科對長期投資者來説是個明智的選擇</li>
</ul>
<p>在相關消息中，內部人士 Gary S. Guthart 於 10 月 24 日星期五出售了 28,800 股公司的股票。該股票以平均價格 547.56 美元出售，總價值為 15,769,728.00 美元。交易完成後，該內部人士直接持有 27,027 股公司股票，價值約為 14,798,904.12 美元。這筆交易代表其持股比例減少了 51.59%。該交易已在證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。此外，首席執行官 David J. Rosa 於 10 月 24 日星期五出售了 24,500 股公司的股票。該股票以平均價格 547.55 美元出售，總交易額為 13,414,975.00 美元。出售後，首席執行官直接持有 234,256 股公司股票，價值為 128,266,872.80 美元。這筆交易使其持股比例減少了 9.47%。該出售的 SEC 備案提供了更多信息。在過去三個月中，內部人士已出售 109,043 股公司股票，價值為 60,816,225 美元。當前 0.70% 的股票由公司內部人士持有。</p>
<h2>對直覺外科的對沖基金看法</h2>
<p>幾家對沖基金最近對 ISRG 的持倉進行了調整。Alecta Tjanstepension Omsesidigt 在第三季度將其在直覺外科的股份增加了 25.4%。Alecta Tjanstepension Omsesidigt 目前持有 212,800 股該醫療設備提供商的股票，價值為 95,160,000 美元，此前在該期間內又購買了 43,100 股。Saranac Partners Ltd 在第三季度購買了直覺外科的新股份，價值約為 4,325,000 美元。瑞士人壽資產管理有限公司在第三季度將其在直覺外科的股份增加了 7.7%。瑞士人壽資產管理有限公司目前持有 67,483 股該醫療設備提供商的股票，價值為 30,180,000 美元，此前在該期間內又收購了 4,824 股。Cambria Investment Management L.P.在第三季度購買了直覺外科的新股份，價值約為 318,000 美元。最後，KERR FINANCIAL PLANNING Corp 在第三季度購買了直覺外科的新股份，價值約為 33,000 美元。當前 83.64% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>關於直覺外科</h2>
<p>（獲取免費報告）</p>
<p>直覺外科公司開發、製造和銷售產品，使醫生和醫療服務提供者能夠提高美國及國際上微創護理的質量和可及性。該公司提供達芬奇手術系統，能夠以微創方式進行復雜手術；以及 Ion 內腔系統，擴展其商業產品範圍，涵蓋微創肺活檢的診斷程序。</p>
<h2>另見</h2>
<ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>股票行業對成功投資的重要性是什麼？</li>
<li>4 只填補重油缺口的加拿大石油股票</li>
<li>什麼是支撐位？</li>
<li>分紅強者：3 只為長期投資而生的藍籌股</li>
<li>最佳能源股票 - 現在值得購買的能源股票</li>
<li>2026 年應避免的 3 只最近被下調評級的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
<p>在考慮直覺外科之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
<p>雖然直覺外科目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

直覺外科

<p>富國銀行將直覺外科（NASDAQ:ISRG）的目標價格從 600 美元上調至 654 美元，維持 “增持” 評級，表明潛在上漲幅度為 19.48%。其他券商也調整了他們的目標價格，普遍評級為 “適度買入”，目標價格為 608.79 美元。直覺外科報告了強勁的季度收益，超出預期，內部人士最近出售了股份。對沖基金也調整了在該公司的持倉</p>

<p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective upped by Wells Fargo &amp; Company from $600.00 to $654.00 in a report issued on Friday,MarketScreener reports. The brokerage currently has an &#34;overweight&#34; rating on the medical equipment provider's stock. Wells Fargo &amp; Company's target price indicates a potential upside of 19.48% from the company's previous close.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）在週五發佈的報告中，Wells Fargo &amp; Company 將其目標價格從 600.00 美元上調至 654.00 美元，MarketScreener 報道。該券商目前對這家醫療設備提供商的股票給予 “增持” 評級。Wells Fargo &amp; Company 的目標價格表明，相較於公司之前的收盤價，存在 19.48% 的潛在上漲空間。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Intuitive Surgical</strong> 警報：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 億美元的內部交易：這對 KMI、ISRG 和 QS 可能意味着什麼</li>
</ul>
</div><p>A number of other brokerages also recently issued reports on ISRG. Leerink Partners upped their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 22nd. Sanford C. Bernstein restated an &#34;outperform&#34; rating and set a $685.00 price target on shares of Intuitive Surgical in a research report on Tuesday, October 21st. BTIG Research raised their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, October 22nd. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Finally, Hsbc Global Res upgraded shares of Intuitive Surgical to a &#34;strong-buy&#34; rating in a research note on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $608.79.</p>
<div class="lb-trans"><p>其他一些券商最近也發佈了關於 ISRG 的報告。Leerink Partners 將直覺外科的目標價格從 593.00 美元上調至 600.00 美元，並在 10 月 22 日的研究報告中給予該公司 “跑贏大盤” 評級。Sanford C. Bernstein 在 10 月 21 日的研究報告中重申了 “跑贏大盤” 評級，並設定了 685.00 美元的目標價格。BTIG Research 在 10 月 22 日的報告中將直覺外科的目標價格從 529.00 美元上調至 589.00 美元，並給予該股票 “買入” 評級。Weiss Ratings 在 10 月 31 日的研究報告中重申了對直覺外科股票的 “持有（c）” 評級。最後，HSBC Global Research 在 10 月 23 日的研究報告中將直覺外科的股票評級上調至 “強力買入”。兩位股票研究分析師給予該股票 “強力買入” 評級，十六位給予 “買入” 評級，八位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票的共識評級為 “適度買入”，共識目標價格為 608.79 美元。</p>
</div><p><strong>View Our Latest Research Report on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我們關於直覺外科的最新研究報告</strong></p>
</div><h2>Intuitive Surgical Stock Performance</h2>
<div class="lb-trans"><h2>直覺外科股票表現</h2>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普關税政策下表現突出的三隻股票</li>
</ul>
</div><p>NASDAQ:ISRG opened at $547.36 on Friday. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50-day moving average price of $527.82 and a two-hundred day moving average price of $505.98. The firm has a market cap of $196.22 billion, a price-to-earnings ratio of 72.40, a price-to-earnings-growth ratio of 5.11 and a beta of 1.68.</p>
<div class="lb-trans"><p>NASDAQ:ISRG 週五開盤價為 547.36 美元。直覺外科的 52 周低點為 425.00 美元，52 周高點為 616.00 美元。該公司的 50 日移動平均價格為 527.82 美元，200 日移動平均價格為 505.98 美元。該公司的市值為 1962.2 億美元，市盈率為 72.40，市盈增長比率為 5.11，貝塔值為 1.68。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical's quarterly revenue was up 22.9% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical will post 6.43 earnings per share for the current year.</p>
<div class="lb-trans"><p>直覺外科（NASDAQ:ISRG - 獲取免費報告）最近於 10 月 21 日發佈了其財報。這家醫療設備提供商報告本季度每股收益（EPS）為 2.40 美元，超出市場共識預期的 1.99 美元，超出幅度為 0.41 美元。該公司本季度的收入為 25.1 億美元，而分析師預期為 24.1 億美元。直覺外科的股本回報率為 15.08%，淨利潤率為 28.58%。直覺外科的季度收入同比增長 22.9%。在去年同期，該公司每股收益為 1.84 美元。整體來看，賣方分析師預測直覺外科在當前年度的每股收益將達到 6.43 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼直覺外科對長期投資者來説是個明智的選擇</li>
</ul>
</div><p>In related news, insider Gary S. Guthart sold 28,800 shares of the firm's stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the transaction, the insider directly owned 27,027 shares of the company's stock, valued at approximately $14,798,904.12. This trade represents a 51.59% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the business's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 109,043 shares of company stock valued at $60,816,225. 0.70% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，內部人士 Gary S. Guthart 於 10 月 24 日星期五出售了 28,800 股公司的股票。該股票以平均價格 547.56 美元出售，總價值為 15,769,728.00 美元。交易完成後，該內部人士直接持有 27,027 股公司股票，價值約為 14,798,904.12 美元。這筆交易代表其持股比例減少了 51.59%。該交易已在證券交易委員會的備案中披露，相關信息可通過此鏈接訪問。此外，首席執行官 David J. Rosa 於 10 月 24 日星期五出售了 24,500 股公司的股票。該股票以平均價格 547.55 美元出售，總交易額為 13,414,975.00 美元。出售後，首席執行官直接持有 234,256 股公司股票，價值為 128,266,872.80 美元。這筆交易使其持股比例減少了 9.47%。該出售的 SEC 備案提供了更多信息。在過去三個月中，內部人士已出售 109,043 股公司股票，價值為 60,816,225 美元。當前 0.70% 的股票由公司內部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Intuitive Surgical</h2>
<div class="lb-trans"><h2>對直覺外科的對沖基金看法</h2>
</div><p>Several hedge funds have recently made changes to their positions in ISRG. Alecta Tjanstepension Omsesidigt boosted its stake in Intuitive Surgical by 25.4% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 212,800 shares of the medical equipment provider's stock worth $95,160,000 after purchasing an additional 43,100 shares during the period. Saranac Partners Ltd purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $4,325,000. Swiss Life Asset Management Ltd boosted its position in shares of Intuitive Surgical by 7.7% in the third quarter. Swiss Life Asset Management Ltd now owns 67,483 shares of the medical equipment provider's stock valued at $30,180,000 after acquiring an additional 4,824 shares during the period. Cambria Investment Management L.P. bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $318,000. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in Intuitive Surgical during the third quarter valued at approximately $33,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>幾家對沖基金最近對 ISRG 的持倉進行了調整。Alecta Tjanstepension Omsesidigt 在第三季度將其在直覺外科的股份增加了 25.4%。Alecta Tjanstepension Omsesidigt 目前持有 212,800 股該醫療設備提供商的股票，價值為 95,160,000 美元，此前在該期間內又購買了 43,100 股。Saranac Partners Ltd 在第三季度購買了直覺外科的新股份，價值約為 4,325,000 美元。瑞士人壽資產管理有限公司在第三季度將其在直覺外科的股份增加了 7.7%。瑞士人壽資產管理有限公司目前持有 67,483 股該醫療設備提供商的股票，價值為 30,180,000 美元，此前在該期間內又收購了 4,824 股。Cambria Investment Management L.P.在第三季度購買了直覺外科的新股份，價值約為 318,000 美元。最後，KERR FINANCIAL PLANNING Corp 在第三季度購買了直覺外科的新股份，價值約為 33,000 美元。當前 83.64% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>關於直覺外科</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直覺外科公司開發、製造和銷售產品，使醫生和醫療服務提供者能夠提高美國及國際上微創護理的質量和可及性。該公司提供達芬奇手術系統，能夠以微創方式進行復雜手術；以及 Ion 內腔系統，擴展其商業產品範圍，涵蓋微創肺活檢的診斷程序。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>Why Are Stock Sectors Important to Successful Investing?</li>
<li>4 Canadian Oil Stocks That Are Filling the Heavy Crude Gap</li>
<li>What is a support level?</li>
<li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li>
<li>Best Energy Stocks - Energy Stocks to Buy Now</li>
<li>3 Recently Downgraded Stocks to Avoid in 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比直覺外科更好的股票</li>
<li>股票行業對成功投資的重要性是什麼？</li>
<li>4 只填補重油缺口的加拿大石油股票</li>
<li>什麼是支撐位？</li>
<li>分紅強者：3 只為長期投資而生的藍籌股</li>
<li>最佳能源股票 - 現在值得購買的能源股票</li>
<li>2026 年應避免的 3 只最近被下調評級的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在直覺外科嗎？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮直覺外科之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而直覺外科並不在名單上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然直覺外科目前在分析師中有中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

富國銀行公司對直覺外科（NASDAQ 代碼：ISRG）的股票價格發佈了樂觀的預測